Position:
Chief Medical Officer at MyoKardia, Inc., Trustee at Lankenau Institute for Medical Research, Adjunct Asst Clinical Professor of Medicine at University of Pennsylvania School of Medicine
Work:
MyoKardia, Inc.
- San Francisco Bay Area since Jan 2013
-
Chief Medical Officer
Lankenau Institute for Medical Research
- Wynnewood, PA since 2001
-
Trustee
University of Pennsylvania School of Medicine
since 1998
-
Adjunct Asst Clinical Professor of Medicine
Nigel-Montgomery, LLC
- Greater Philadelphia Area Jul 2012 - Jan 2013
-
Consultant
AstraZeneca
- Wilmington, DE Jan 2004 - Jul 2012
-
Vice President, Clinical Therapeutic Area, CV&GI
FDA CardioRenal Advisory Committee
2007 - 2011
-
Industry Representative
Merck Research Laboratories
2001 - 2004
-
Senior Director, Clinical Research
GlaxoSmithKline
1998 - 2000
-
Director, Clinical Pharmacology and Experimental Medicine
University of Pennsylvania School of Medicine
1993 - 1998
-
Asst Professor of Medicine (Cardiology)
Education:
Duke University School of Medicine 1987 - 1993
Residency in Internal Medicine; Fellowship in Cardiovascular Diseases
University of Chicago - The Pritzker School of Medicine 1979 - 1987
MD, PhD, Medicine, Pathology
University of Chicago 1975 - 1979
AB, Biology
MIT-Sloane School of Management 1999 - 1999
Harvard Business School 2011 - 2011